• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Need for improved outcome measures in pulmonary arterial hypertension related to systemic sclerosis.

作者信息

Distler O, Behrens F, Huscher D, Foeldvari I, Zink A, Nash P, Denton C P, Humbert M, Matucci-Cerinic M, Seibold J, Rubin L, Furst D E

出版信息

Rheumatology (Oxford). 2006 Dec;45(12):1455-7. doi: 10.1093/rheumatology/kel273. Epub 2006 Aug 18.

DOI:10.1093/rheumatology/kel273
PMID:16920751
Abstract
摘要

相似文献

1
Need for improved outcome measures in pulmonary arterial hypertension related to systemic sclerosis.系统性硬化症相关肺动脉高压中改善结局指标的必要性。
Rheumatology (Oxford). 2006 Dec;45(12):1455-7. doi: 10.1093/rheumatology/kel273. Epub 2006 Aug 18.
2
[Pulmonary arterial hypertension in collagen disease: findings of the German Network for Systemic Scleroderma].
Dtsch Med Wochenschr. 2007 Feb 16;132(7):337; author reply 338. doi: 10.1055/s-2007-970340.
3
Defining appropriate outcome measures in pulmonary arterial hypertension related to systemic sclerosis: a Delphi consensus study with cluster analysis.定义与系统性硬化症相关的肺动脉高压的适当结局指标：一项采用聚类分析的德尔菲共识研究。
Arthritis Rheum. 2008 Jun 15;59(6):867-75. doi: 10.1002/art.23718.
4
A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonism.硬皮病相关肺动脉高压管理的新时代：内皮素受体拮抗剂治疗
Ann Rheum Dis. 2004 Sep;63(9):1009-14. doi: 10.1136/ard.2003.017673.
5
Pulmonary arterial hypertension: are we doing enough to identify systemic sclerosis patients at high risk of this rare condition?肺动脉高压：我们在识别系统性硬化症患者中这种罕见病症的高风险人群方面做得够吗？
Rheumatology (Oxford). 2005 Feb;44(2):141-2. doi: 10.1093/rheumatology/keh474.
6
Ivabradine in systemic sclerosis related pulmonary arterial hypertension.
Eur J Intern Med. 2012 Dec;23(8):e210-1. doi: 10.1016/j.ejim.2012.09.008. Epub 2012 Sep 26.
7
[Pulmonary arterial hypertension in connective tissue disease].[结缔组织病中的肺动脉高压]
Rev Mal Respir. 2006 Sep;23(4 Suppl):13S61-72.
8
Pulmonary hypertension in systemic sclerosis: bete noire no more?系统性硬化症中的肺动脉高压：不再是棘手难题了？
Curr Opin Rheumatol. 2002 Nov;14(6):666-70. doi: 10.1097/00002281-200211000-00007.
9
Outcome measures in pulmonary arterial hypertension associated with systemic sclerosis.系统性硬化症相关肺动脉高压的结局指标
Rheumatology (Oxford). 2008 Oct;47 Suppl 5:v39-41. doi: 10.1093/rheumatology/ken308.
10
Effect of ambrisentan on digital ulcers in systemic sclerosis: a case report.
Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-230-1. Epub 2014 Apr 28.

引用本文的文献

1
Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials.结缔组织病相关间质性肺疾病和特发性肺纤维化：临床试验中使用的暂定核心领域和工具集。
Thorax. 2014 May;69(5):428-36. doi: 10.1136/thoraxjnl-2013-204202. Epub 2013 Dec 24.
2
Development of Clinical Trial Assessments for the Study of Interstitial Lung Disease in Patients who have Connective Tissue Diseases-Methodological Considerations.针对患有结缔组织病的间质性肺病患者研究的临床试验评估的发展——方法学考量
Curr Rheumatol Rev. 2010 May 1;6(2):145-150. doi: 10.2174/157339710791330713.
3
Clinical trials and basic research: defining mechanisms and improving treatment in connective tissue disease.
临床试验与基础研究：明确结缔组织病的发病机制并改善其治疗方法
Arthritis Res Ther. 2007;9 Suppl 2(Suppl 2):S10. doi: 10.1186/ar2194.